Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Daiichi Sankyo
Federal Trade Commission
US Department of Justice
Chubb
Boehringer Ingelheim

Generated: May 20, 2019

DrugPatentWatch Database Preview

Details for Patent: 5,795,911

« Back to Dashboard

Which drugs does patent 5,795,911 protect, and when does it expire?

Patent 5,795,911 protects VEREGEN and is included in one NDA.

This patent has thirteen patent family members in nine countries.

Summary for Patent: 5,795,911
Title: Composition for treating Condyloma acuminata
Abstract:A composition for a treatment of HPV-infected Condyloma acuminata which comprises containing tea catechin as a main component. This medication has no danger of side-effects and may be easily applied to or inserted in the infected area by the patient themselves.
Inventor(s): Cheng; Shu Jun (Beijing, CN), Wang; De Chang (Beijing, CN), Hara; Yukihiko (Fujieda, JP)
Assignee: Cancer Institute (Hospital), Chinese Academy of Medical Sciences (Beijing, CN) Mitsui Norin Co., Ltd. (Tokyo, JP)
Application Number:08/835,920
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 5,795,911
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;

Drugs Protected by US Patent 5,795,911

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Fougera Pharms Inc VEREGEN sinecatechins OINTMENT;TOPICAL 021902-001 Oct 31, 2006 RX Yes Yes ➤ Sign Up ➤ Sign Up TREATMENT OF GENITAL WARTS ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,795,911

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan8-321195Nov 18, 1996

International Family Members for US Patent 5,795,911

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 288266 ➤ Sign Up
Australia 4443897 ➤ Sign Up
Australia 716120 ➤ Sign Up
Canada 2221370 ➤ Sign Up
China 1086290 ➤ Sign Up
China 1185947 ➤ Sign Up
Germany 122009000072 ➤ Sign Up
Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Chubb
Deloitte
Accenture
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.